Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 16356838)

1.

Expression of sFRP-4 and beta-catenin in human colorectal carcinoma.

Feng Han Q, Zhao W, Bentel J, Shearwood AM, Zeps N, Joseph D, Iacopetta B, Dharmarajan A.

Cancer Lett. 2006 Jan 8;231(1):129-37.

PMID:
16356838
2.

Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.

Lugli A, Zlobec I, Minoo P, Baker K, Tornillo L, Terracciano L, Jass JR.

Histopathology. 2007 Mar;50(4):453-64.

PMID:
17448021
3.

Tumor buds show reduced expression of laminin-5 gamma 2 chain in DNA mismatch repair deficient colorectal cancer.

Shinto E, Baker K, Tsuda H, Mochizuki H, Ueno H, Matsubara O, Foulkes WD, Jass JR.

Dis Colon Rectum. 2006 Aug;49(8):1193-202.

PMID:
16773493
4.

Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.

Ortega P, Morán A, de Juan C, Frías C, Hernández S, López-Asenjo JA, Sánchez-Pernaute A, Torres A, Iniesta P, Benito M.

Clin Cancer Res. 2008 Feb 15;14(4):995-1001. doi: 10.1158/1078-0432.CCR-07-1588.

5.

Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.

Lüchtenborg M, Weijenberg MP, Wark PA, Saritas AM, Roemen GM, van Muijen GN, de Bruïne AP, van den Brandt PA, de Goeij AF.

BMC Cancer. 2005 Dec 15;5:160.

6.

Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray.

Xie D, Sham JS, Zeng WF, Lin HL, Che LH, Wu HX, Wen JM, Fang Y, Hu L, Guan XY.

Int J Cancer. 2003 Dec 20;107(6):896-902.

PMID:
14601048
7.

Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.

Pancione M, Forte N, Fucci A, Sabatino L, Febbraro A, Di Blasi A, Daniele B, Parente D, Colantuoni V.

Hum Pathol. 2010 Jun;41(6):867-76. doi: 10.1016/j.humpath.2009.09.019. Epub 2010 Feb 4.

PMID:
20129645
8.

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.

Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG, Baylin SB.

Nat Genet. 2004 Apr;36(4):417-22. Epub 2004 Mar 14.

PMID:
15034581
9.

Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.

Lavergne E, Hendaoui I, Coulouarn C, Ribault C, Leseur J, Eliat PA, Mebarki S, Corlu A, Clément B, Musso O.

Oncogene. 2011 Jan 27;30(4):423-33. doi: 10.1038/onc.2010.432. Epub 2010 Sep 20.

10.

Beta-catenin expression in relation to genetic instability and prognosis in colorectal cancer.

Mårtensson A, Oberg A, Jung A, Cederquist K, Stenling R, Palmqvist R.

Oncol Rep. 2007 Feb;17(2):447-52.

PMID:
17203186
11.

APC and beta-catenin protein expression patterns in HNPCC-related endometrial and colorectal cancers.

Kariola R, Abdel-Rahman WM, Ollikainen M, Butzow R, Peltomäki P, Nyström M.

Fam Cancer. 2005;4(2):187-90.

PMID:
15951972
12.

Correlation of Wnt-2 expression and beta-catenin intracellular accumulation in Chinese gastric cancers: relevance with tumour dissemination.

Cheng XX, Wang ZC, Chen XY, Sun Y, Kong QY, Liu J, Li H.

Cancer Lett. 2005 Jun 8;223(2):339-47. Epub 2004 Dec 13.

PMID:
15896469
13.

Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer.

Nojima M, Suzuki H, Toyota M, Watanabe Y, Maruyama R, Sasaki S, Sasaki Y, Mita H, Nishikawa N, Yamaguchi K, Hirata K, Itoh F, Tokino T, Mori M, Imai K, Shinomura Y.

Oncogene. 2007 Jul 12;26(32):4699-713. Epub 2007 Feb 5.

PMID:
17297461
14.

Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.

Chetty R, Serra S, Salahshor S, Alsaad K, Shih W, Blaszyk H, Woodgett JR, Tsao MS.

Hum Pathol. 2006 Feb;37(2):212-7.

PMID:
16426922
15.

Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.

Yin YJ, Katz V, Salah Z, Maoz M, Cohen I, Uziely B, Turm H, Grisaru-Granovsky S, Suzuki H, Bar-Shavit R.

Cancer Res. 2006 May 15;66(10):5224-33.

16.

DICKKOPF-4 and -2 genes are upregulated in human colorectal cancer.

Matsui A, Yamaguchi T, Maekawa S, Miyazaki C, Takano S, Uetake T, Inoue T, Otaka M, Otsuka H, Sato T, Yamashita A, Takahashi Y, Enomoto N.

Cancer Sci. 2009 Oct;100(10):1923-30. doi: 10.1111/j.1349-7006.2009.01272.x. Epub 2009 Jul 2.

PMID:
19659606
17.

Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients.

Lanza G, Gafà R, Santini A, Maestri I, Guerzoni L, Cavazzini L.

J Clin Oncol. 2006 May 20;24(15):2359-67.

18.

Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.

Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8606-14.

19.

Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysis.

Al-Kuraya KS, Bavi PP, Ezzat AA, Al-Dayel FA, Uddin S, Atizado VL, Al-Jomah NA, Amr SS, Sheikh SS, Sauter G, Simon R.

Saudi Med J. 2006 Mar;27(3):323-8.

PMID:
16532091
20.

beta-Catenin, Nf-kappaB and FAS protein expression are independent events in head and neck cancer: study of their association with clinical parameters.

Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Sanchez-Verde L, Alameda F, Ballestin C, Sanchez-Cespedes M.

Cancer Lett. 2005 Dec 8;230(1):141-8.

PMID:
16253770
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk